Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study.

Manchanda R, Burnell M, Gaba F, Sanderson S, Loggenberg K, Gessler S, Wardle J, Side L, Desai R, Brady AF, Dorkins H, Wallis Y, Chapman C, Jacobs C, Tomlinson I, Beller U, Menon U, Jacobs I.

BJOG. 2019 May;126(6):784-794. doi: 10.1111/1471-0528.15654. Epub 2019 Mar 18.

PMID:
30767407
2.

Recurrence of endometrial carcinoma presenting as vulvar lesions.

Rottenstreich M, Armon S, Beller U, Rosengarten O, Vernea F, Reichman O.

Int J Gynaecol Obstet. 2019 Apr;145(1):123-124. doi: 10.1002/ijgo.12762. Epub 2019 Feb 6.

PMID:
30653661
3.

Letter From Editor October 2018.

Beller U.

Int J Gynecol Cancer. 2018 Oct;28(8):1447. doi: 10.1097/IGC.0000000000001355. No abstract available.

PMID:
30247246
4.

September Letter from the Editor.

Beller U.

Int J Gynecol Cancer. 2018 Sep;28(7):1247. doi: 10.1097/IGC.0000000000001353. No abstract available.

PMID:
30142122
5.

Letter From Editor July 2018.

Beller U.

Int J Gynecol Cancer. 2018 Jul;28(6):1057. doi: 10.1097/IGC.0000000000001322. No abstract available.

PMID:
29975289
6.

Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group Study.

Yagur Y, Weitzner O, Gemer O, Lavie O, Beller U, Bruchim I, Vaknin Z, Levy T, Rabinovich A, Shachar IB, Meirovitz A, Arie AB, Derazne E, Raban O, Eitan R, Kadan Y, Fishman A, Helpman L.

Gynecol Oncol. 2018 Aug;150(2):288-292. doi: 10.1016/j.ygyno.2018.05.016. Epub 2018 May 26.

PMID:
29807695
7.

Letter From Editor June 2018.

Beller U.

Int J Gynecol Cancer. 2018 Jun;28(5):853. doi: 10.1097/IGC.0000000000001297. No abstract available.

PMID:
29782481
8.

Letter From Editor May 2018.

Beller U.

Int J Gynecol Cancer. 2018 May;28(4):656. doi: 10.1097/IGC.0000000000001274. No abstract available.

PMID:
29688968
9.

Impact of BRCA mutations on outcomes among patients with serous endometrial cancer.

Kadan Y, Raviv O, Segev Y, Lavie O, Bruchim I, Fishman A, Michaelson R, Beller U, Helpman L.

Int J Gynaecol Obstet. 2018 Jul;142(1):91-96. doi: 10.1002/ijgo.12486. Epub 2018 Apr 2.

PMID:
29572834
10.

Letter From the Editor, March 2018.

Beller U.

Int J Gynecol Cancer. 2018 Feb 22. doi: 10.1097/IGC.0000000000001226. [Epub ahead of print] No abstract available.

PMID:
29470189
11.

Letter From the Editor.

Beller U.

Int J Gynecol Cancer. 2018 Mar;28(3):425. doi: 10.1097/IGC.0000000000001226. No abstract available.

PMID:
29465504
12.

Letter From Editor: January 2018.

Beller U.

Int J Gynecol Cancer. 2018 Jan;28(1):1. doi: 10.1097/IGC.0000000000001153. No abstract available.

PMID:
29206663
13.

Letter From the Editor-November 2017.

Beller U.

Int J Gynecol Cancer. 2017 Nov;27(9):1803. doi: 10.1097/IGC.0000000000001123. No abstract available.

PMID:
30814153
14.

Letter From the Editor-November 2017.

Beller U.

Int J Gynecol Cancer. 2017 Nov;27(9):1803. doi: 10.1097/IGC.0000000000001123. No abstract available.

PMID:
29064912
15.

Letter From the Editor-October 2017.

Beller U.

Int J Gynecol Cancer. 2017 Oct;27(8):1569. doi: 10.1097/IGC.0000000000001099. No abstract available.

PMID:
28885272
16.

Letter from the Editor.

Beller U.

Int J Gynecol Cancer. 2017 Sep;27(7):1305. doi: 10.1097/IGC.0000000000001080. No abstract available.

PMID:
30814236
17.

Letter from the Editor.

Beller U.

Int J Gynecol Cancer. 2017 Sep;27(7):1305. doi: 10.1097/IGC.0000000000001080. No abstract available.

PMID:
28832387
18.

Letter from the Editor.

Beller U.

Int J Gynecol Cancer. 2017 Jul;27(6):1059. doi: 10.1097/IGC.0000000000001055. No abstract available.

PMID:
30814191
19.

Letter from the Editor.

Beller U.

Int J Gynecol Cancer. 2017 Jul;27(6):1059. doi: 10.1097/IGC.0000000000001055. No abstract available.

PMID:
28640174
20.

Letter From the Editor, June 2017.

Beller U.

Int J Gynecol Cancer. 2017 Jun;27(5):853. doi: 10.1097/IGC.0000000000001024. No abstract available.

PMID:
28525496
21.

Letter from the Editor.

Beller U.

Int J Gynecol Cancer. 2017 May;27(4):627. doi: 10.1097/IGC.0000000000000994. No abstract available.

PMID:
30814175
22.

Letter from the Editor.

Beller U.

Int J Gynecol Cancer. 2017 May;27(4):627. doi: 10.1097/IGC.0000000000000994. No abstract available.

PMID:
28441248
23.

Letter from the Editor.

Beller U.

Int J Gynecol Cancer. 2017 Mar;27(3):411. doi: 10.1097/IGC.0000000000000955. No abstract available.

PMID:
28212141
24.

Letter From the Editor - February 2017.

Beller U.

Int J Gynecol Cancer. 2017 Feb;27(2):195. doi: 10.1097/IGC.0000000000000941. No abstract available.

PMID:
30814223
25.

Letter From the Editor - February 2017.

Beller U.

Int J Gynecol Cancer. 2017 Feb;27(2):195. doi: 10.1097/IGC.0000000000000941. No abstract available.

PMID:
28114229
26.

January Editorial.

Beller U.

Int J Gynecol Cancer. 2017 Jan;27(1):1. doi: 10.1097/IGC.0000000000000916. No abstract available.

PMID:
28002206
27.

Letter From Editor-November 2016.

Beller U.

Int J Gynecol Cancer. 2016 Nov;26(9):1545. doi: 10.1097/IGC.0000000000000889. No abstract available.

PMID:
30814199
28.

Letter From Editor-November 2016.

Beller U.

Int J Gynecol Cancer. 2016 Nov;26(9):1545. No abstract available.

PMID:
27779543
29.

Letter From Editor-October 2016.

Beller U.

Int J Gynecol Cancer. 2016 Oct;26(8):1365. doi: 10.1097/IGC.0000000000000847. No abstract available.

PMID:
30814132
30.

Letter From Editor-October 2016.

Beller U.

Int J Gynecol Cancer. 2016 Oct;26(8):1365. doi: 10.1097/IGC.0000000000000847. No abstract available.

PMID:
27648711
31.

Letter From Editor-September 2016.

Beller U.

Int J Gynecol Cancer. 2016 Sep;26(7):1189. doi: 10.1097/IGC.0000000000000807. No abstract available.

PMID:
27643644
32.

Letter From Editor - July 2016.

Beller U.

Int J Gynecol Cancer. 2016 Jul;26(6):991. doi: 10.1097/IGC.0000000000000793. No abstract available.

PMID:
30814166
33.

Letter From Editor - July 2016.

Beller U.

Int J Gynecol Cancer. 2016 Jul;26(6):991. doi: 10.1097/IGC.0000000000000793. No abstract available.

PMID:
27327147
34.

Letter from Editor.

Beller U.

Int J Gynecol Cancer. 2016 Jun;26(5):809. doi: 10.1097/IGC.0000000000000760. No abstract available.

PMID:
30814140
35.

Letter from Editor.

Beller U.

Int J Gynecol Cancer. 2016 Jun;26(5):809. doi: 10.1097/IGC.0000000000000760. No abstract available.

PMID:
27206215
36.

Letter from Editor.

Beller U.

Int J Gynecol Cancer. 2016 May;26(4):607. doi: 10.1097/IGC.0000000000000732. No abstract available.

PMID:
30814158
37.

Letter from Editor.

Beller U.

Int J Gynecol Cancer. 2016 May;26(4):607. doi: 10.1097/IGC.0000000000000732. No abstract available.

PMID:
27101521
38.

Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations.

Manchanda R, Burnell M, Loggenberg K, Desai R, Wardle J, Sanderson SC, Gessler S, Side L, Balogun N, Kumar A, Dorkins H, Wallis Y, Chapman C, Tomlinson I, Taylor R, Jacobs C, Legood R, Raikou M, McGuire A, Beller U, Menon U, Jacobs I.

J Med Genet. 2016 Jul;53(7):472-80. doi: 10.1136/jmedgenet-2015-103740. Epub 2016 Mar 18.

PMID:
26993268
39.

Letter From the Editor.

Beller U.

Int J Gynecol Cancer. 2016 Mar;26(3):423. doi: 10.1097/IGC.0000000000000691. No abstract available.

PMID:
26894936
40.

Letter From the Editor.

Beller U.

Int J Gynecol Cancer. 2016 Feb;26(2):223. doi: 10.1097/IGC.0000000000000633. No abstract available.

PMID:
26807557
41.

January Editorial.

Beller U.

Int J Gynecol Cancer. 2016 Jan;27(1):1. doi: 10.1097/IGC.0000000000000916. No abstract available.

PMID:
30814183
42.

Letter From the Editor.

Beller U.

Int J Gynecol Cancer. 2016 Jan;26(1):1. doi: 10.1097/IGC.0000000000000610. No abstract available.

PMID:
26658361
43.

Letter From the Editor.

Beller U.

Int J Gynecol Cancer. 2015 Nov;25(9):1547. doi: 10.1097/IGC.0000000000000599. No abstract available.

PMID:
26495756
44.

Editorial.

Beller U.

Int J Gynecol Cancer. 2015 Sep;25(7):1143. doi: 10.1097/IGC.0000000000000573. No abstract available.

PMID:
26302214
45.

This is our first editorial to appear in an electronic-only format. Introduction.

Beller U.

Int J Gynecol Cancer. 2015 Jan;25(1):1. doi: 10.1097/IGC.0000000000000342. No abstract available.

PMID:
25525767
46.

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.

Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, Beller U, Menon U, Jacobs I.

J Natl Cancer Inst. 2014 Nov 30;107(1):380. doi: 10.1093/jnci/dju380. Print 2015 Jan.

47.

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.

Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, McGuire A, Beller U, Menon U, Jacobs I.

J Natl Cancer Inst. 2014 Nov 30;107(1):379. doi: 10.1093/jnci/dju379. Print 2015 Jan.

48.

The fall season regularly brings with it one of two biennial meetings of our mother societies. Introduction.

Beller U.

Int J Gynecol Cancer. 2014 Oct;24(8):1357. doi: 10.1097/IGC.0000000000000283. No abstract available.

PMID:
25248110
49.

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.

Gabai-Kapara E, Lahad A, Kaufman B, Friedman E, Segev S, Renbaum P, Beeri R, Gal M, Grinshpun-Cohen J, Djemal K, Mandell JB, Lee MK, Beller U, Catane R, King MC, Levy-Lahad E.

Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14205-10. doi: 10.1073/pnas.1415979111. Epub 2014 Sep 5.

50.

Integration of PET/CT into the preoperative evaluation of patients with early cervical cancer does not decrease the proportion of patients with positive lymph nodes found after surgery.

Gemer O, Eitan R, Gdalevich M, Mamanov A, Piura B, Rabinovich A, Levavi H, Saar-Ryss B, Halperin R, Finci S, Beller U, Bruchim I, Levy T, Ben-Shachar I, Meirovitz A, Arie AB, Lavie O.

Int J Gynecol Cancer. 2014 Oct;24(8):1461-5. doi: 10.1097/IGC.0000000000000251.

PMID:
25188884

Supplemental Content

Loading ...
Support Center